Work-In-Progress Seminar
Work-In-Progress Seminar
For the intensive exchange of information on the current state of the projects, all doctoral students will present and discuss the research results during the work-in-progress seminar in the presence of their supervisor team.
The work-in-progress seminar is combined with the scientific colloquium.
Summer Semester 2022
The colloquia will take place in lecture hall 6A starting at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 25.04.22 | Prof. Dr. Nadine Ziemert, University Hospital Tübingen,Translational Natural Product Genomics | A Genome Mining Pipeline for antibiotic discovery in bacteria |
| 02.05.22 | Progress Reports | |
| Larissa Hinz | Modular synthesis of Indolophenazine-Derivatives as active agents against Toxoplasma gondii | |
| Stefan Höfmann | Development of novel 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway inhibitors | |
| 09.05.22 | Prof. Dr. Thomas Efferth, Institute of Pharmaceutical and Biomedical Sciences, Johannes-von-Gutenberg-University, Mainz tba | |
| 16.05.22 | Progress Reports | |
| Lars Seiffert | tba | |
| Julian Schliehe-Diecks | tba | |
| 23.05.22 | Dr. Maximilian Barth, Institute of Pharmaceutical and Medicinal Chemistry, HHU | Drug Metabolism and Pharmacokinetics in Drug Discovery and the DMPK Service Unit at IPMC |
| 30.05.22 | Progress Reports | |
| Korana Mudrovcic | tba | |
| Annabelle Friedrich | tba | |
| 13.06.22 | Prof. Dr. Christian Ducho, Pharmazeutische und Medizinische Chemie, Saarland University | Medicinal Chemistry with Naturally Occurring Nucleoside Antibiotics |
| 20.06.22 | Progress Reports | |
| Talea Knak | tba | |
| Ilka Hinxlage | tba | |
| 27.06.22 | Prof. Dr. Nicole Teusch, Pharmaceutical Biology and Biotechnology, HHU | tba |
| 04.07.22 | Progress Reports | |
| Mariam Dubiel | tba | |
| Julia Gottstein | tba |
Winter Semester 2021/2022
The colloquia will start at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 04.10.21 | Dr. Christopher Stroh, Director Translational and Biomarker Research, Merck Group | A precision medicine approach to target the receptor tyrosine kinase MET in cancer |
| 18.10.21 | Information event on the Feodor Lynen Fellowship of the Alexander von Humboldt Foundation | |
| 25.10.21 | Prof. Dr. Heike Brötz-Oesterhelt, Interfaculty Institute of Microbiology and Infection Medicine, Microbial Bioactive Compounds, University Tübingen | Antibiotic Modes of Action - Technologies & Research Stories |
| 08.11.21 | Prof. Dr. Andreas Reichert, Institute of Biochemistry and Molecular Biology I, Heinrich-Heine-University Düsseldorf | Structure-function relations of mitochondria |
| 15.11.21 | Progress Reports | |
| Julia Gottstein | Lantibiotic resistance in human pathogens | |
| Mariam Dubiel | Histamine H4 receptors in cancer - perspectives as potential molecular target | |
| 29.11.21 | Progress Reports (lecture hall 5H) | |
| Emmanuel Adeniyi | Characterization of molecular mechanisms underlying antimycobacterial activity of callyaerins | |
| Xiaoli Yang | Beauvericin exhibits immunostimulatory effects on conventional dendritic cells via activating the TLR4 signaling pathwaysistant tumors and bacterial pathogens | |
| 06.12.21 | Dr. Jan Bülle, Kutzenberger Wolff & Partner, Partner, Dipl. Chem., Patentanwalt, European Patent & Trademark Attorney | Brief Introduction to the Patent System |
| 13.12.21 | Progress Reports (lecture hall 5H) | |
| Moritz Klischan | Biaryl-based natural products as structural motif for pharmaceutically relevant compounds | |
| Lena Berning | Characterization of autophagy-modulating natural products and derivatives for the elimination of therapy-resistant tumor cells | |
| 10.01.22 | Prof. Dr. Alice McHardy, Computational Biology of Infection Research, Helmholtz Centre for Infection Research | Critical Assessment of Metagenome Interpretation - the second round of challenges |
| 17.01.22 | Progress Reports (lecture hall 5H) | |
| Marlena Sekeres | Modulation of the DNA damage response (DDR) by natural compounds (NC) to widen the therapeutic window of anticancer drugs | |
| Pablo Cea | Structure based drug design against Nisin resistance systems | |
| 24.01.22 | Prof. Dr. Robin Teufel, Pharmaceutical Biology Division, Department of Pharmaceutical Sciences, University of Basel | Insights into the biosynthesis of bioactive bacterial tropone and polyketide natural products |
| 31.01.22 | Progress Reports (via Webex) | |
| Fabian Fischer | Development of HDAC-inhibitors and HDAC-PROTACs | |
| Flaminia Mazzone | Identification and characterization of new natural products with antimicrobial activity against Toxoplasma gondii |
Summer Semester 2021
The colloquia will take place as online meetings starting at 4:30 pm. The invitation link will be send by email.
| Date | Speakers | Title |
|---|---|---|
| 19.04.21 | Progress Reports | |
| Flaminia Mazzone | Identification and characterization of new natural products with anti-microbial activity against Apicomplexa and multiresistant gram-negative rods (4MRGN) | |
| Laura Mayer | Diversity-oriented synthesis of diaryl substituted heterocycles via sequential palladium catalysis | |
| 26.04.21 | Progress Reports | |
| Pablo Cea | Structural studies of nisin resistance and immunity systems | |
| Lars Seiffert | Synthesis of small-molecule inhibitors of nisin resistance protein | |
| 10.05.21 | Progress Reports | |
| Julian Schliehe-Diecks | Characterization of synergy and resistance traits of HSP90 and HDAC inhibitors in leukemic cell lines | |
| Fabian Fischer | Development of chemosensitizing HDAC-Inhibitors and HDAC-PROTACs | |
| 17.05.21 | Dr. Christine Beemelmanns, Junior Research Group Leader Chemical Biology of Microbe-Host Interactions, Leibniz Institute for Natural Product Research and Infection Biology e.V., Hans-Knöll-Institute (HKI) | Novel Secondary Metabolites from Microbial Interactions |
| 31.05.21 | Prof. Dr. Dominic Hoepfner, Director Genomic Sciences, Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research | How to catch a target: genetic fishing expeditions with natural products |
| 07.06.21 | Progress Reports | |
| Korana Mudrovcic | Exploration of Strategies to Disrupt ULK1 Protein Complex and Chlorflavonin Optimization | |
| Annabelle Friedrich | Targeting protein-protein interactions within the autophagy-inducing ULK1 complex for cancer therapy | |
| 14.06.21 | Dr. Bert Klebl, Managing Director and Chief Scientific Officer of Lead Discovery Center GmbH, Dortmund, Germany | Pandemic Prepardness – a Pathoblocker Concept to Inhibit S. aureus Induced Infections |
| 21.06.21 | Progress Reports | |
| Talea Knak | Structural optimization of Chlorflavonin – a natural product with antimycobacterial activity | |
| Ilka Hinxlage | Identification of Novel Apoptotic Signaling Pathways for the Elimination of Therapy-Resistant Tumors | |
| 28.06.21 | Dr. Elke Röhrdanz, Head of the Unit Reproductive and Genetic Toxicology, BfArM (Federal Institute for Drugs and Medical Devices) | Non-clinical Drug Development |
| 05.07.21 | cancelled | |
| 12.07.21 | Prof. Dr. Zoe Waibler, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel | Batch testing and batch release of immunological biomedicines in Germany |